Cargando…
Butein activates p53 in hepatocellular carcinoma cells via blocking MDM2-mediated ubiquitination
INTRODUCTION: In this study, we aimed to investigate the effect of butein on p53 in hepatocellular carcinoma (HCC) cells and the related molecular mechanisms by which p53 was activated. METHODS: MTS assay and clonogenic survival assay were used to examine the antitumor activity of butein in vitro. R...
Autores principales: | Zhou, Yuanfeng, Wang, Kuifeng, Zhou, Ni, Huang, Tingting, Zhu, Jiansheng, Li, Jicheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898589/ https://www.ncbi.nlm.nih.gov/pubmed/29670376 http://dx.doi.org/10.2147/OTT.S160119 |
Ejemplares similares
-
Butein suppresses hepatocellular carcinoma growth via modulating Aurora B kinase activity
por: Zhou, Yuanfeng, et al.
Publicado: (2018) -
Butein promotes ubiquitination-mediated survivin degradation inhibits tumor growth and overcomes chemoresistance
por: Dong, Xin, et al.
Publicado: (2022) -
p53 causes butein-mediated apoptosis of chronic myeloid leukemia cells
por: WOO, SANG-MI, et al.
Publicado: (2016) -
Author Correction: Butein promotes ubiquitination-mediated survivin degradation inhibits tumor growth and overcomes chemoresistance
por: Dong, Xin, et al.
Publicado: (2023) -
Butein Inhibited In Vitro Hexokinase-2-Mediated Tumor Glycolysis in Hepatocellular Carcinoma by Blocking Epidermal Growth Factor Receptor (EGFR)
por: Liao, Weirong, et al.
Publicado: (2018)